Search
Close this search box.
Search
[custom_company_search_form]
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)

Stock Piper AI Index

Subscribe
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)

Argenica Therapeutics Ltd

AGN

ASX

Argenica Therapeutics Limited (AGN) is actively engaged in pioneering research and development focused on neuroprotective therapeutic drugs. Their primary objective is to innovate novel treatments aimed at mitigating brain damage following stroke. By advancing these neuroprotective therapies, Argenica Therapeutics seeks to address critical needs in stroke care, potentially improving outcomes and quality of life for patients affected by this debilitating condition.

Latest Posts

Line Chart with Gradient
Price
$0.78
-0.015 (-1.9%)
At Close 20/09 (AEST)
Related Companies
PACIFIC EDGE LIMITED
$PEB
DORSAVI LTD
$DVL
DIMERIX LIMITED
$DXB
ACRUX LIMITED
$ACR
AUSCANN GROUP HOLDINGS LTD
$AC8

Latest Posts

AGN

$AGN

Argenica Therapeutics (ASX: $AGN) progresses phase 2 stroke trial

DSMB recommends continuation of ARG-007 trial with no modifications

AGN

$AGN

Argenica Therapeutics (ASX: $AGN) demonstrates efficacy of ARG-007 in reducing traumatic brain injury effects

Study shows significant reduction in brain cell damage and inflammation markers in ferret model

AGN

$AGN

Argenica Therapeutics (ASX: $AGN) commences phase 2 stroke trial

Successfully dosed first patients in ARG-007 trial, granted Rare Pediatric Disease Designation

AGN

$AGN

Argenica Therapeutics (ASX: $AGN) completes $12.0m placement

Successfully raises funds to progress Phase 2 trial of ARG-007 in ischaemic stroke patients

AGN

$AGN

Argenica Therapeutics (ASX: $AGN) achieves patient dosing milestone in stroke trial

First cohort of acute ischaemic stroke patients dosed in Phase 2 clinical trial of ARG-007

AGN

$AGN

Argenica Therapeutics (ASX: $AGN) requests trading halt for capital raising announcement

Company requests halt ahead of capital raising news

AGN

$AGN

Argenica Therapeutics (ASX: $AGN) doses first patient in phase 2 stroke trial of ARG-007

Phase 2 trial commences with successful dosing of acute ischaemic stroke patient

AGN

$AGN

Argenica Therapeutics (ASX: $AGN) progresses phase 2 stroke clinical trial

Manufacturing of drug substance completed, hospital trial sites set up, and independent DSMB established

AGN

$AGN

Argenica Therapeutics (ASX:$AGN) progresses phase 2 stroke clinical trial

Manufacturing of drug substance completed, hospital trial sites set up, and independent DSMB established

Related Companies
PRESCIENT THERAPEUTICS LIMITED
$PTX
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED
$MVP
RACE ONCOLOGY LTD
$RAC
RECCE PHARMACEUTICALS LTD
$RCE
ANTEOTECH LTD
$ADO

ASX News, First
& Fast.

By clicking Subscribe, you agree to our Terms & Conditions

ASX News, First And Fast.

By clicking Subscribe, you agree to our Terms & Conditions

© 2024 Stock Piper. All rights reserved

© 2024 Stock Piper.
All rights reserved

Blog

Healthcare
Materials
Real Estate
Consumer Staples
Consumer Discretionary Brief
Utilities

Company

About us
Terms of use
Privacy Policy

Support

Request Form
Contact Support
FAQ
Glossary

Socials

Facebook
Twitter
LinkedIn
© 2024 Stock Piper. All rights reserved
Social Media Auto Publish Powered By : XYZScripts.com
Join FREE Newsletter

Stock Piper AI Index Coming Soon!

Join our Newsletter to gain exclusive insight and be notified once we are live.

By clicking Subscribe, you agree to our Terms & Conditions

ASX News, First And Fast.

Get all the latest market updates straight to your inbox.

By clicking Subscribe, you agree to our Terms & Conditions